Table 5 Association between circadian rhythm and MCI or cognitive impairment assessed by CMMSE in study population.
Community referents | Pneumoconiosis patients | |||
|---|---|---|---|---|
NC/MCI | AOR (95% CI) | NC/MCI | AOR (95% CI) | |
Percent rhythm a | ||||
≥ 17.8 | 61/38 | 1.00 (ref) | 48/28 | 0.73 (0.36, 1.51) |
< 17.8 | 71/23 | 0.48 (0.24, 0.95) ** | 45/44 | 1.16 (0.58, 2.31) |
Amplitude a | ||||
≥ 120.8 | 77/29 | 1.00 (ref) | 50/28 | 1.13 (0.54, 2.34) |
< 120.8 | 55/32 | 1.11 (0.56, 2.21) | 43/44 | 1.62 (0.80, 3.25) |
MESOR a | ||||
≥ 254.8 | 81/32 | 1.00 (ref) | 50/26 | 1.11 (0.54, 2.27) |
< 254.8 | 51/29 | 1.23 (0.61, 2.49) | 43/46 | 1.74 (0.88, 3.44) |
Acrophase a | ||||
≥ 13.8 | 78/29 | 1.00 (ref) | 42/38 | 1.89 (0.92, 3.90) * |
< 13.8 | 54/32 | 1.05 (0.51, 2.15) | 51/34 | 0.95 (0.45, 2.03) |
NC/Composite outcomes of MCI plus CI | AOR (95% CI) | NC/Composite outcomes of MCI plus CI | AOR (95% CI) | |
|---|---|---|---|---|
Percent rhythm a | ||||
≥ 17.8 | 61/45 | 1.00 (ref) | 48/43 | 0.89 (0.46, 1.76) |
< 17.8 | 71/31 | 0.52 (0.27, 1.00) ** | 45/50 | 1.04 (0.53, 2.05) |
Amplitude a | ||||
≥ 120.8 | 77/33 | 1.00 (ref) | 50/37 | 1.26 (0.64, 2.51) |
< 120.8 | 55/43 | 1.25 (0.65, 2.41) | 43/56 | 1.66 (0.84, 3.26) |
MESOR a | ||||
≥ 254.8 | 81/37 | 1.00 (ref) | 50/30 | 1.09 (0.55, 2.18) |
< 254.8 | 51/39 | 1.49 (0.76, 2.89) | 43/63 | 1.99 (1.04, 3.81) ** |
Acrophase a | ||||
≥ 13.8 | 78/35 | 1.00 (ref) | 42/42 | 1.65 (0.82, 3.33) |
< 13.8 | 54/41 | 1.03 (0.52, 2.02) | 51/51 | 1.10 (0.55, 2.23) |